文献速递甲状腺疾病

苯丁酸钠挽救脑内皮样细胞中的甲状腺激素转运

Sodium Phenylbutyrate Rescues Thyroid Hormone Transport in Brain Endothelial-Like Cells.
PubMed 文献 · Thyroid · 2022-04-26

本研究利用诱导多能干细胞衍生的脑微血管内皮样细胞(iBMECs)作为人源生理相关细胞模型,测试化学伴侣苯丁酸钠(NaPB)对MCT8-P321L突变体的作用。结果显示NaPB可恢复突变MCT8表达及转运功能,并上调MCT10表达、增加三碘甲状腺原氨酸摄取,同时通过未知T4转运体增加甲状腺素摄取。作者认为NaPB有望用于特定MCT8缺乏症病例的再利用研究。

要点

  • NaPB可稳定iBMECs中MCT8-P321L突变体表达并恢复其转运功能。
  • NaPB处理后MCT10表达上调,参与三碘甲状腺原氨酸摄取。
  • NaPB处理后甲状腺素摄取增加由未知T4转运体介导,不依赖MCT8。

核心结论

  • NaPB可在人源细胞模型中稳定一种致病性错义突变,并以不依赖MCT8的方式激活甲状腺激素转运,为在特定MCT8缺乏症病例中再利用美国食品药品监督管理局批准的NaPB提供了未来研究基础。

研究设计与样本

  • 研究使用诱导多能干细胞衍生的脑微血管内皮样细胞(iBMECs)作为人源生理相关细胞模型,通过蛋白质印迹和放射性摄取实验检测NaPB对突变MCT8表达和功能的影响。

主要发现

  • 在携带患者突变MCT8-P321L的iBMECs中,NaPB挽救了降低的突变MCT8表达并恢复了转运功能。
  • 研究鉴定MCT10为iBMECs中参与三碘甲状腺原氨酸摄取的替代甲状腺激素转运体,NaPB处理后MCT10表达上调。
  • NaPB处理后甲状腺素摄取增加,该增加不由被挽救的MCT8介导,而由一种未鉴定的T4转运体介导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Monocarboxylate transporter 8 (MCT8) deficiency is a rare genetic disease leading to a severe developmental delay due to a lack of thyroid hormones (THs) during critical stages of human brain development. Some MCT8-deficient patients are not as severely affected as others. Previously, we hypothesized that these patients' mutations do not affect the functionality but destabilize the MCT8 protein, leading to a diminished number of functional MCT8 molecules at the cell surface. Methods: We have already demonstrated that the chemical chaperone sodium phenylbutyrate (NaPB) rescues the function of these mutants by stabilizing their protein expression in an overexpressing cell system. Here, we expanded our previous work and used iPSC (induced pluripotent stem cell)-derived brain microvascular endothelial-like cells (iBMECs) as a physiologically relevant cell model of human origin to test for NaPB responsiveness. The effects on mutant MCT8 expression and function were tested by Western blotting and radioactive uptake assays. Results: We found that NaPB rescues decreased mutant MCT8 expression and restores transport function in iBMECs carrying patient's mutation MCT8-P321L. Further, we identified MCT10 as an alternative TH transporter in iBMECs that contributes to triiodothyronine uptake, the biological active TH. Our results indicate an upregulation of MCT10 after NaPB treatment. In addition, we detected an increase in thyroxine (T4) uptake after NaPB treatment that was not mediated by rescued MCT8 but an unidentified T4 transporter. Conclusions: We demonstrate that NaPB is suitable to stabilize a pathogenic missense mutation in a human-derived cell model. Further, it activates TH transport independent of MCT8. Both options fuel future studies to investigate repurposing the Food and Drug Administration-approved drug NaPB in selected cases of MCT8 deficiency.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Braun D, Bohleber S, Vatine GD, et al. Sodium Phenylbutyrate Rescues Thyroid Hormone Transport in Brain Endothelial-Like Cells. Thyroid. 2022. PMID: 35357974. doi:10.1089/thy.2021.0643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。